LSV Asset Management
IRMD icon

LSV Asset Management’s iRadimed IRMD Stock Holding History

LSV Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,600
Closed -$554K – 851
2024
Q2 		$554K Hold
12,600
– – ﹤0.01% 717
2024
Q1 		$554K Sell
12,600
-4,800
-28% -$212K ﹤0.01% 726
2023
Q4 		$826K Hold
17,400
– – ﹤0.01% 704
2023
Q3 		$772K Hold
17,400
– – ﹤0.01% 704
2023
Q2 		$831K Hold
17,400
– – ﹤0.01% 713
2023
Q1 		$685K Sell
17,400
-900
-5% -$32.7K ﹤0.01% 694
2022
Q4 		$518K Buy
+18,300
New +$524K ﹤0.01% 719

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management's IRMD Position: Q3 2024 in Review

LSV Asset Management sold out of iRadimed (IRMD) in Q3 2024, closing a stake of 12,600 shares — an estimated $554K sold.

LSV Asset Management first reported a position in IRMD in Q4 2022 and held it in 7 quarters. The position peaked at $831K in Q2 2023. 145 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.

  • LSV Asset Management reported no remaining iRadimed position as of Q3 2024 after selling out during the quarter.
  • LSV Asset Management sold 12,600 iRadimed shares in Q3 2024, an estimated $554K.
  • LSV Asset Management first reported a position in iRadimed in Q4 2022 and held it in 7 quarters.
  • LSV Asset Management's iRadimed position peaked at $831K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.

Based on LSV Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.